Legacy Capital Group California’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-12,480
Closed -$299K – 312
2026
Q1
$299K Sell
12,480
-8,508
-41% -$208K 0.11% 239
2025
Q4
$475K Buy
20,988
+632
+3% +$13.8K 0.12% 218
2025
Q3
$410K Buy
20,356
+1,349
+7% +$22.6K 0.1% 232
2025
Q2
$271K Buy
19,007
+1,321
+7% +$15.4K 0.08% 283
2025
Q1
$186K Buy
17,686
+1,695
+11% +$19.2K 0.06% 300
2024
Q4
$194K Buy
+15,991
New +$209K 0.06% 325

Other funds holding ELAN

Legacy Capital Group California's ELAN Position: Q2 2026 in Review

Legacy Capital Group California sold out of Elanco Animal Health (ELAN) in Q2 2026, closing a stake of 12,480 shares — an estimated $299K sold.

Legacy Capital Group California first reported a position in ELAN in Q4 2024 and held it in 6 quarters. The position peaked at $475K in Q4 2025. 524 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Legacy Capital Group California reported no remaining Elanco Animal Health position as of Q2 2026 after selling out during the quarter.
  • Legacy Capital Group California sold 12,480 Elanco Animal Health shares in Q2 2026, an estimated $299K.
  • Legacy Capital Group California first reported a position in Elanco Animal Health in Q4 2024 and held it in 6 quarters.
  • Legacy Capital Group California's Elanco Animal Health position peaked at $475K in Q4 2025.
  • 524 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Legacy Capital Group California's 13F filing for Q2 2026, filed 29 Jul 2026.